Velcade: Cancer Therapy
VELCADE® is the first oncology drug marketed and promoted by Millennium. The rapid clinical development of VELCADE-with FDA approval granted little more than four and a half years after initiation of the first clinical trial-reflects our intense commitment to novel treatments for cancer patients. To discover and develop such treatments, we focus on understanding key molecular pathways that play crucial roles in underlying disease processes, and on identifying therapeutically significant differences that may exist between people.
Embed code for Blogs
Simply copy and paste the following HTML code below into your blog, website, or MySpace profile.
Copy to Clipboard
Share this video:
Simply click the button below and select your social bookmarking site.
Tag Cloud
Category: Health & Care
VELCADE® is the first oncology drug marketed and promoted by Millennium. The rapid clinical development of VELCADE-with FDA approval granted little more than four and a half years after initiation of the first clinical...
Tags:
myeloma, drugs, treatment, patients, mcl, mantle cell lymphoma, fda, velcade, therapy, cancer, health
Views: 11534















UNICEF: Sri Lankan cricket stars join fight against HIV in South Africa
AARP: Safely disposing expired prescriptions
Sonal Shah, initiative leader of Fuel the Growth of Small and Medium-Sized Enterprises (SMEs)
SAS, 60 years of history
Water safety tips from American Red Cross health and safety expert, Connie Harvey
Ride Smarter Chicago Transit on Google Maps
National Institute on Drug Abuse: Text Message
UNICEF: Gender Equality - Marisa
Michael Wamithi, East Africa regional director
UNICEF: Children affected by HIV-AIDS meet parliamentarians at Mozambique conference
UNICEF Helping children cope after violence in Gaza
General Motors: New Engine Technology
Project Aware: Ed Harris
American Lung Association: Freedom from Smoking 2
UNICEF 60th anniversary 1960-1979: the development decades
General Motors: Hip Hop Booster Seats